Definition, Diagnostic Criteria & Classification
| Question | Answer |
|---|---|
| 1. Detail the etiology and pathogenesis of Enteric (Typhoid) Fever. | - Etiology: Salmonella enterica serovars Typhi and Paratyphi A, B, and C (Gram-negative, flagellated, facultative intracellular bacilli). - Pathogenetic Pathway: 1) Ingestion of contaminated food/water $\to$ bacilli survive gastric acid barrier. 2) Bacilli adhere to and invade intestinal microfold cells (M cells) overlying Peyer's patches in the terminal ileum. 3) Internalized by macrophages $\to$ survive and multiply intracellularly in Salmonella-containing vacuoles (SCVs) using Type III Secretion System (T3SS) effectors. 4) Disseminate via mesenteric lymphatics to the thoracic duct $\to$ Transient Primary Bacteremia. 5) Seed the reticuloendothelial system (liver, spleen, bone marrow) and gallbladder during the asymptomatic incubation period (7-14 days). 6) Secondary sustained bacteremia ensues with release of endotoxin (LPS), causing fever, toxemia, and reseeding of the intestinal lymphoid tissue with necrosis of Peyer's patches. |
| 2. Describe the classical weekly evolution of untreated Enteric Fever. | - Week 1 (Step-ladder Fever): Insidious onset of fever rising in a step-ladder fashion over 5-7 days, associated with headache, malaise, anorexia, dry cough, and relative bradycardia (Faget's sign). - Week 2 (Toxemia & Organomegaly): Sustained high-grade remittent fever ($39-40^\circ\text{C}$), "pea-soup" diarrhea or obstinate constipation, marked apathy/delirium, abdominal distension with right iliac fossa tenderness, hepatosplenomegaly, and transient Rose spots (faint salmon-pink blanching macules on lower chest/abdomen). - Week 3 (Complications Phase): Severe toxemia, "typhoid state" (coma vigil, muttering delirium), and catastrophic vascular complications: Intestinal Perforation and Severe Gastrointestinal Hemorrhage. - Week 4 (Defervescence or Relapse): Gradual lysis of fever over several days, or emergence of relapse (in $5-10\%$) or chronic gallbladder carriage. |
| 3. What are the major life-threatening complications of Enteric Fever? | 1) Intestinal Perforation: Occurs in $1-3\%$ of hospitalized patients, typically in the 3rd week. Site: Terminal ileum ($<60\text{ cm}$ from ileocecal valve) on the antimesenteric border. 2) Gastrointestinal Hemorrhage: Severe bleeding from eroded submucosal vessels in ulcerated Peyer's patches ($2-10\%$). 3) Typhoid Encephalopathy: Delirium, coma vigil, tremors, myoclonus; carries mortality $>20-30\%$. 4) Cardiovascular: Toxic myocarditis (arrhythmias, heart failure). 5) Hematologic: Disseminated Intravascular Coagulation (DIC), secondary Hemophagocytic Lymphohistiocytosis (Typhoid-induced HLH). 6) Hepatobiliary: Acute acalculous cholecystitis, typhoid hepatitis. |
| 4. What are the diagnostic modalities for Enteric Fever, and when is each most sensitive? | - Blood Culture: Investigation of choice in the 1st week of illness (sensitivity $60-80\%$; declines to $30-40\%$ in 3rd week or after prior antibiotics). - Bone Marrow Culture: Gold standard test; highest sensitivity ($>90\%$) regardless of prior antibiotic treatment or week of illness. - Stool Culture: Positive in $30-40\%$ in the 2nd and 3rd weeks; valuable for carrier detection. - Urine Culture: Positive in 2nd-3rd weeks ($5-10\%$). - Widal Test: Tube agglutination measuring antibodies against O (somatic) and H (flagellar) antigens. (See Viva Trap for limitations). |
| 5. VIVA TRAP: What is "Relative Bradycardia" (Faget's Sign), and why is it often absent in young children? | - Definition: A pulse rate that fails to rise proportionately with body temperature (normally, pulse rises by $10\text{ beats/minute}$ for every $1^\circ\text{F}$ [$0.55^\circ\text{C}$] rise in core temperature above normal). In enteric fever, high fever is accompanied by an unexpectedly low heart rate. - Mechanism: Autonomic baroreceptor dysfunction or direct myocardial depression by Salmonella endotoxin. - VIVA TRAP in Pediatrics: Relative bradycardia is unreliable and rarely seen in young children ($<5$ years)! Infants and young children with typhoid typically mount severe physiological tachycardia in response to high fever, toxemia, and dehydration! |
Pathophysiology & Complications
| Question | Answer |
|---|---|
| 6. Detail the surgical anatomy and pathophysiology of Typhoid Intestinal Perforation. | - Pathogenesis: In the 3rd week, intense hyperplasia of lymphoid follicles in Peyer's patches undergoes ischemic necrosis, followed by mucosal sloughing, leaving deep, punched-out oval ulcers oriented along the longitudinal axis of the bowel. - Location: Ulcer necrosis erodes through the muscularis and serosa, almost always located on the antimesenteric border of the terminal ileum within 30 to 60 cm of the ileocecal valve. - Clinical Presentation: Sudden acute deterioration: abrupt severe abdominal pain, localized or generalized guarding and rigidity, rising tachycardia, sudden drop in fever (due to endotoxic shock), and absent bowel sounds. - Radiology: Erect chest X-ray or abdominal radiograph demonstrates Pneumoperitoneum (free air under the right hemidiaphragm). |
| 7. Define Multi-Drug Resistant (MDR) and Extensively Drug-Resistant (XDR) Salmonella Typhi. | - MDR S. Typhi: Strains resistant to all three historical first-line conventional agents: Chloramphenicol, Ampicillin, and Trimethoprim-Sulfamethoxazole (Co-trimoxazole). - Fluoroquinolone-Resistant (Nalidixic Acid Resistant - NARST): Resistant to ciprofloxacin/ofloxacin due to mutations in the gyrA and parC genes. - XDR S. Typhi: Strains resistant to first-line agents (Ampicillin, Chloramphenicol, Cotrimoxazole) PLUS Fluoroquinolones (Ciprofloxacin) PLUS Third-Generation Cephalosporins (Ceftriaxone, Cefixime)! Characterized by plasmid-mediated $bla_{\text{CTX-M-15}}$ extended-spectrum $\beta$-lactamase (ESBL). First emerged in Pakistan and rapidly spreading globally. |
| 8. VIVA TRAP: What are the fundamental flaws of the Widal Test in clinical practice? | The Widal test is notoriously plagued by poor sensitivity and specificity: 1) False Positives: Cross-reactivity with other enterobacteriaceae, non-typhoidal salmonellae, malaria, dengue, acute hepatitis, or previous TAB/typhoid vaccination ("anamnestic response"). 2) False Negatives: Up to $30\%$ of culture-proven typhoid cases have non-diagnostic titers due to prior antibiotics or blunted immune response. 3) Timing: Agglutinins only appear by the end of the 1st week; a single acute titer is uninterpretable without knowing the endemic baseline titer of the local community. - Diagnostic standard: A four-fold rise in paired sera collected 10-14 days apart, or single titers $\text{TO} \ge 1:160$ and $\text{TH} \ge 1:160$ in non-vaccinated individuals in endemic areas. Never start or withhold treatment based solely on a borderline Widal test! |
Guidelines & Management Protocols (IAP & WHO Guidelines)
| Question | Answer |
|---|---|
| 9. Detail the empirical and culture-directed antibiotic regimens for Enteric Fever in children. | 1) Uncomplicated Suspected Ceftriaxone-Susceptible Enteric Fever: - Ceftriaxone: $75\text{ to } 100\text{ mg/kg/day}$ IV once daily or divided q12h for 10 to 14 days, OR - Azithromycin: $20\text{ mg/kg/day}$ orally once daily for 7 to 10 days (excellent intracellular penetration; low relapse rate). 2) Extensively Drug-Resistant (XDR) Typhoid Fever: - Meropenem: $60\text{ to } 100\text{ mg/kg/day}$ IV divided q8h for 10 to 14 days, PLUS/MINUS - Azithromycin: $20\text{ mg/kg/day}$ orally for 7-10 days. 3) Fully Susceptible Strains (De-escalation): Amoxicillin ($100\text{ mg/kg/day}$) or Co-trimoxazole ($8\text{ mg/kg/day}$ TMP) if proven sensitive on culture. |
| 10. What is the role of High-Dose Dexamethasone in Complicated Enteric Fever? | - Indication: Severe Typhoid Encephalopathy characterized by delirium, obtundation, coma, stupor, or shock. - Regimen: Dexamethasone $3.0\text{ mg/kg}$ IV loading dose over 30 minutes, followed by $1.0\text{ mg/kg}$ IV every 6 hours for 48 hours (8 additional doses). - Evidence: Landmark clinical trials demonstrated an astonishing reduction in mortality from $55\%$ down to $10\%$ in severe typhoid encephalopathy when steroids were added to effective antibiotics! |
| 11. What is the expected time to defervescence after starting effective antibiotic therapy? | - Even with highly effective, culture-sensitive antibiotics (e.g., Ceftriaxone or Azithromycin), the mean time to complete defervescence is 4 to 6 days (96 to 144 hours)! - Clinical Pearl: Enteric fever resolves by gradual "Lysis", not by sudden crisis. Do NOT switch antibiotics on day 2 or 3 simply because the child is still spiking fevers, provided the child's toxemia is improving, sensorium is clear, and complications are ruled out! |
VIVA TRAPs & Counter-Questions
| Question | Answer |
|---|---|
| 12. VIVA TRAP: A child with typhoid fever is treated with Ceftriaxone. On Day 14, fever resolves and the child is discharged. Ten days later, high fever recurs. Blood culture is again positive for S. Typhi. Is this a new infection or a Relapse? How is it managed? | - Diagnosis: Typhoid Relapse. - Pathophysiology: Relapse occurs in $5-15\%$ of treated patients, characteristically 1 to 3 weeks after completing antibiotics. Relapse is caused by reactivation of the same endogenous intracellular strain persisting within macrophages in bone marrow or mesenteric lymph nodes, NOT by reinfection! - Resistance TRAP: Relapse organisms almost always demonstrate the IDENTICAL antibiotic sensitivity profile as the original isolate! - Management: Re-treat with a second full course of the same effective antibiotic or switch to Azithromycin ($20\text{ mg/kg/day}$ for 10-14 days) to ensure deep intracellular eradication! |
| 13. Counter-Question Chain: "Define a Chronic Typhoid Carrier, and what is the management?" | - Definition: Excretion of Salmonella Typhi in stool or urine for more than 12 months following acute infection (occurs in $1-4\%$ of adults, rare in young children; strongly associated with biliary tract abnormalities like gallstones or urinary schistosomiasis). - Carrier Reservoir: The Gallbladder is the primary anatomical reservoir (biofilm formation on gallstones). - Medical Eradication: High-dose oral Amoxicillin ($100\text{ mg/kg/day}$) PLUS Probenecid for 4 to 6 weeks, OR oral Ciprofloxacin ($750\text{ mg}$ BID in adults / $30\text{ mg/kg/day}$ in children) for 4 weeks. - Surgical Management: If cholelithiasis is present and medical eradication fails, Cholecystectomy cures $>85-90\%$ of chronic carriers. |